Tag: survey

Needs assessment

Posted on by Milutin

Our member organisation Re Generation will implement the research study ‘’The needs assessment among Ukrainian refugees and Russian migrants in the Republic of Serbia on access to services and new psychoactive substances/stimulant use’’. The survey is part of the “Emergency support for the provision of HIV and Harm Reduction services among key populations in Ukraine and refugees in selected neighbouring countries” project funded by the United Nations Office on Drugs and Crime (UNODC).

This research study aims to estimate the level of new psychoactive substances/stimulants used among Ukrainian refugees and Russian migrants as well as understand what the Republic of Serbia should do in the future to ensure that the Ukrainian refugees and Russian migrants have access to services that will improve their social and health status in the humanitarian settings.

If you are a Ukrainian refugee or Russian migrant in the Republic of Serbia, please see the s urvey, more information, and consent form in English here>>>.

Please remember the following:

  • Participation in this research is voluntary, confidential and free,
  • You do not have to decide today whether or not you will participate in the research,
  • Before you decide, you can talk to anyone you feel comfortable with about the research.

 

Sexual violence when out at night

Posted on by Milutin

From the Sexism Free Night project website

The research activities of Sexism Free Night were based in a Europe-wide websurvey aimed at collect information on the prevalence of sexism and sexual violence among over-18s in Europe, and to analyse its intersections with specific key factors such as patterns of drug use, participation in nightlife and party environments, nightlife mobility and beliefs about sexual violence.

We have asked questions about people’s nightlife experiences, acknowledging the COVID19 pandemic happening at the time of survey launching. The time frame included going out before the covid-19 outbreak and also going out in the context of social isolation (e.g. small parties or meetings at home, in nature or public spaces with friends, informal parties in hidden locations or video calls and live streaming events).

The survey was developed and translated into eight different languages: English, Spanish, French, Portuguese, Serbian, German, Latvian and Slovenian, while data collection was implemented from 25.11.2020 until 31.12.2020.

Total number of web survey respondents from European countries was 10.148, while 4534 people completed the survey in full and were considered for the analysis. Results of the survey also served for later design of our European Campaign and Training.

To read full report follow this link>>>.

 

European Web Survey on Drugs 2021

Posted on by Milutin

From the EMCDDA press release

The EU drugs agency (EMCDDA) published today results of the European Web Survey on Drugs. The survey ran between March and April 2021 in 30 countries (21 EU and 9 non-EU) when many populations were under COVID-19-related lockdowns. Targeted at people aged 18 and over who have used drugs, the survey aims to improve understanding of patterns of drug use in Europe and help shape future drug policies and interventions.

Close to 50 000 adults (48.469) responded to the survey from 21 EU Member States and Switzerland. Cannabis was the drug used most, with 93% of survey respondents reporting to have used it in the previous 12 months and with little variation between countries. MDMA/ecstasy (35%), cocaine (35%) and amphetamine (28%) were the next most reported illicit substances, with the order of the three drugs varying by country. Around a third of respondents (32%) reported using more (herbal) cannabis and 42% using less MDMA/ecstasy.

The survey revealed that one fifth (20%) of the sample reported using LSD in the last year, 16% using new psychoactive substances (NPS) and 13% using ketamine. Heroin use was reported by 3% of respondents. Although the sample reporting heroin use was small, over a quarter of these respondents (26%) reported using this drug more during the period studied.

New to the 2021 round was the participation of the agency’s partners from the Western Balkans, through an EMCDDA technical assistance project (IPA7).

Over 2 000 adults (2 174) from Albania, Kosovo*, Montenegro, North Macedonia and Serbia responded to the survey. Most respondents (91%) reported using cannabis in the previous 12 months, followed by cocaine (38%), MDMA/ecstasy (22%) and amphetamine (20%). Again, around a third of respondents (32%) reported using more (herbal) cannabis and 34% using less MDMA/ecstasy.

Almost one in six (17%) respondents reported using NPS in the last year, while 9% reported use of LSD. Use of both heroin and methamphetamine was reported by 8% of respondents.

Home was reported as the most common setting for drug use during the period (85% of respondents in the EU-Switzerland survey and 72% in the Western Balkans), a pattern accentuated by COVID-19 lockdowns and closure of nightlife venues. Motivation for the use of different substances sheds some light on these results. The most commonly reported motivations for cannabis use were relaxation, getting high and aiding sleep, while for MDMA/ecstasy, they were its euphoric and socialising effects.

 

For more information, visit:

Survey on diagnostics for self-testing in Europe

Posted on by Milutin

The European AIDS Treatment Group (EATG) has launched a survey to map out the pricing and availability of self-test kits for HIV and HCV in the WHO European region.

The aim of this survey is to address the lack of knowledge/awareness of the current pricing and availability of self-test kits for HIV and HCV in the WHO European region. In addition, data collected through this survey will be reported on and disseminated to community members in the autumn of 2021.

The results will also be used to inform key informant interviews in the autumn 2021 to further investigate regulatory, policy context and practical challenges and solutions from a community perspective.

EATG is a patient-led NGO that advocates for the rights and interests of people living with or affected by HIV/ AIDS and related co-infections within the WHO Europe region.

The survey data collection will close on 10 September 2021.

The survey is available following this link>>>.

Research on EU Action Plan on Drugs

Posted on by Milutin

The EU Civil Society Forum on Drugs (CSFD) hosts the survey on Civil Society Perspectives on the implementation of the EU Action Plan on Drugs aiming to assess the state of implementation of the EU Action Plan on Drugs 2017-2020 in the EU Member States and beyond. It is addressed to civil society organisations working in the field of drug policy. The survey is addressed to representatives of civil society working in drug policy and it’s all specific areas.

Following the survey conducted at the beginning of the Action Plan 2017-2020 implementation (report can be accessed here>>>), the CSFD continues the monitoring of accessibility and quality of key demand reduction and harm reduction measures. This survey aims to collect the data allowing for the evaluation of the current situation and identify the potential changes taking place during the last three years. Its results, complemented with other elements of this research project, will be published on the CSFD website.

It is extremely important to collect enough data to be able to see the general picture of the European situation. The CSFD research projects, including this survey, are one of the very few bottom-up attempts to fill this gap in knowledge. Collecting information on the state of key demand and harm reduction services will allow to identify shortcomings and gaps in drug policy implementation in European countries. This, in turn, will serve as information for policy-makers and an advocacy tool for civil society actors at the European, national, and local levels.

The survey is available following this link>>>. Deadline is 12 June 2021.

 

Impact of COVID-19 in Western Balkans

Posted on by Milutin

The EMCDDA has initiated a project investigating the impact of COVID-19 on people who use drugs, drug markets and challenges for drug service provision in the Western Balkans.

The  project is conducted using an adapted version of the Trendspotter methodology with the objective to increase our understanding of the impact of the COVID-19 epidemic and national containment measures on  patterns of drug use, emerging harms and challenges and adaptations of  drug service providers in the Western Balkan region, as well as identify potential national best practices in responding to  this public health challenge. We take a step-wise approach with the first investigation focusing on service provision, followed by drug use patterns and risks and security issues.

The  investigation has multiple components  – namely expert surveys and facilitated groups.

The survey is available here: https://ec.europa.eu/eusurvey/runner/Covid-19-IPA7-health. The deadline for completing it is the 12th of June.

In the second step, EMCDDA will be approaching regional experts from drug services and informed about service provision (OST, needle exchange programmes, harm reduction, treatment, drug services in prisons) in order to get a more in-depth understanding of the developments via facilitated groups.

 

Mini-European Web Survey on Drugs

Posted on by Milutin

In order to investigate and rapidly document the current impact of the COVID-19 epidemics and national responses in the EU Member States on changes in patterns of drug use, harms and service provision, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is carrying out a study using an adapted version of the trendspotter methodology across EU Member States, of which this survey on Impact of COVID-19 on patterns of drug use, harms and drug services in the European Union forms a part. The Mini European Web Survey on Drugs: COVID-19 is part of this snapshot and is being conducted across Europe. The aim is to gather information about how patterns of drug use may have changed in Europe due to COVID-19.

Since the outbreak of COVID-19 across Europe and subsequent national responses to contain and mitigate the epidemic (self-isolation, quarantine, confinement, lockdowns), information has emerged about unprecedented challenges for services providing care to people who use drugs in the community and in prisons. Anecdotal information also indicates that there may have be changes in drug use patterns and in how people are obtaining their drugs. Understanding and sharing information on the consequences of COVID-19 and national response measures on harms deriving from the lack of access to care and how services have adapted as a response may help services improve their responses.

The information collected is entirely confidential and will be kept safely. The questionnaire is also anonymous – although there are a few broad questions about general situation to help understand how different groups of people who use drugs have been affected by the COVID-19 restrictions and how services have responded in different parts of Europe. This will help the sharing of good practice and improved preparedness in the future.

To contribute to the survey, follow this link>>>

Perceptions of substances, public policies and users in France

Posted on by Milutin

Since 1999, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been quantifying the opinions and perceptions of the French population on drugs and related public policies through the EROPP survey (Survey on representations, opinions and perceptions regarding psychoactive drugs). For this fifth edition, a sample of 2.001 individuals, representing the French population aged 18 to 75, was selected based on quota sampling. The survey makes it possible to see how opinions are structured around issues in the public debate but also to consider how opinions in France have developed over the last twenty years. For continuity, most of the themes studied in previous surveys have been kept (for example, the perceived dangerousness of different psychoactive substances, the representation of heroin users and opinions on drug legislation). In addition, questions on current topics and new issues have been added.

In 2018, the EROPP survey, now translated into Englosh, focused on five psychoactive substances: tobacco, alcohol, cannabis, cocaine and heroin. Tendances No. 131 first discusses drug-related knowledge and how dangerous they are perceived to be. Secondly, it reports on individuals’ adherence to public policies that are currently in force or being discussed in France or in other countries. Finally, a final section summarises cannabis users’ opinions through a classification that groups together individuals with similar views. Where possible, the results are compared with those from previous surveys.

To read the survey follow this link>>>

Medicines Shortage Survey

Posted on by Milutin

The EU Civil Society Forum on HIV, TB and Hep working group on access to medicines is inviting you to contribute to a short survey on medicines shortages for the treatment of hepatitis B&C, HIV, TB and OST in 2019. The deadline for contribution is 27 June 23:59 CET.

The data collected and summarized will be used in a meeting with the European Commission with other civil society partners on 1 July 2019 to back a request for an investigation into the causes of shortages in order to improve understanding of the situations and possible solutions.

The survey is not limited to EU countries.

Please, fill in the survey here>>>

LGBT survey on happiness, sex and quality of life

Posted on by Milutin

The LGBT Foundation and the United Nations (UNAIDS) partnered with the Universities of Aix-Marseille and Minnesota for this quick survey on happiness, sex and quality of life. Aim of the survey is to better understand social and legal environments and amplify voices, concerns and needs of these communities.

The survey is available in 17 languages. It takes 12 minutes to complete it.

You must be at least 18-year-old to perform this survey. Your responses are completely anonymous. You can choose to skip any question you would prefer not to answer.

To contribute to the survey, please follow this link>>>>